<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37103756</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>270</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Comparison of spinal magnetic resonance imaging and classical clinical factors in predicting motor capacity in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>3885</StartPage><EndPage>3895</EndPage><MedlinePgn>3885-3895</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-023-11727-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Motor capacity is crucial in amyotrophic lateral sclerosis (ALS) clinical trial design and patient care. However, few studies have explored the potential of multimodal MRI to predict motor capacity in ALS. This study aims to evaluate the predictive value of cervical spinal cord MRI parameters for motor capacity in ALS compared to clinical prognostic factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Spinal multimodal MRI was performed shortly after diagnosis in 41 ALS patients and 12 healthy participants as part of a prospective multicenter cohort study, the PULSE study (NCT00002013-A00969-36). Motor capacity was assessed using ALSFRS-R scores. Multiple stepwise linear regression models were constructed to predict motor capacity at 3 and 6&#xa0;months from diagnosis, based on clinical variables, structural MRI measurements, including spinal cord cross-sectional area (CSA), anterior-posterior, and left-to-right cross-section diameters at vertebral levels from C1 to T4, and diffusion parameters in the lateral corticospinal tracts (LCSTs) and dorsal columns.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Structural MRI measurements were significantly correlated with the ALSFRS-R score and its sub-scores. And as early as 3&#xa0;months from diagnosis, structural MRI measurements fit the best multiple linear regression model to predict the total ALSFRS-R (R<sup>2</sup>&#x2009;=&#x2009;0.70, p value&#x2009;=&#x2009;0.0001) and arm sub-score (R<sup>2</sup>&#x2009;=&#x2009;0.69, p value&#x2009;=&#x2009;0.0002), and combined with DTI metric in the LCST and clinical factors fit the best multiple linear regression model to predict leg sub-score (R<sup>2</sup>&#x2009;=&#x2009;0.73, p value&#x2009;=&#x2009;0.0002).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Spinal multimodal MRI could be promising as a tool to enhance prognostic accuracy and serve as a motor function proxy in ALS.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khamaysa</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, CNRS, INSERM, Laboratoire d'Imagerie Biom&#xe9;dicale, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lefort</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, CNRS, INSERM, Laboratoire d'Imagerie Biom&#xe9;dicale, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;l&#xe9;grini-Issac</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, CNRS, INSERM, Laboratoire d'Imagerie Biom&#xe9;dicale, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lackmy-Vall&#xe9;e</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, CNRS, INSERM, Laboratoire d'Imagerie Biom&#xe9;dicale, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preuilh</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, CNRS, INSERM, Laboratoire d'Imagerie Biom&#xe9;dicale, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devos</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Neurology, Centre R&#xe9;f&#xe9;rent SLA, CHU de Lille, Centre LICEND COEN, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D&#xe9;partment de Pharmacologie M&#xe9;dicale, Universit&#xe9; de Lille, INSERM UMRS_1172 LilNCog, CHU de Lille, Centre LICEND COEN, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rolland</LastName><ForeName>A-S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>D&#xe9;partment de Pharmacologie M&#xe9;dicale, Universit&#xe9; de Lille, INSERM UMRS_1172 LilNCog, CHU de Lille, Centre LICEND COEN, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desnuelle</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Facult&#xe9; M&#xe9;decine de Nice, D&#xe9;partement de Neurologie, Universit&#xe9; Cote d'Azur, Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chupin</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CATI Multicenter Neuroimaging Platform, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchand-Pauvert</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, CNRS, INSERM, Laboratoire d'Imagerie Biom&#xe9;dicale, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Querin</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>APHP, Service de Neuromyologie, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Centre R&#xe9;f&#xe9;rent Maladies Neuromusculaires Rares, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Myologie, I-Motion Clinical Trials Platform, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pradat</LastName><ForeName>Pierre-Fran&#xe7;ois</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, CNRS, INSERM, Laboratoire d'Imagerie Biom&#xe9;dicale, Paris, France. pierre-francois.pradat@aphp.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APHP, D&#xe9;partement de Neurologie, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Centre R&#xe9;f&#xe9;rent SLA, Paris, France. pierre-francois.pradat@aphp.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Northern Ireland Centre for Stratified Medicine, Biomedical Sciences Research Institute Ulster University, C-TRIC, Altnagelvin Hospital, Derry/Londonderry, UK. pierre-francois.pradat@aphp.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Pulse study group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011712" MajorTopicYN="N">Pyramidal Tracts</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Disease progression rate</Keyword><Keyword MajorTopicYN="N">Motor neuron disorder</Keyword><Keyword MajorTopicYN="N">Spinal cord MRI</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Danel-Brunaud</LastName><ForeName>Veronique</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moreau</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perez</LastName><ForeName>Thierry</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dumont</LastName></Investigator><Investigator ValidYN="Y"><LastName>Dujardin</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delval</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gel&#xe9;</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pleuvret</LastName><ForeName>Marie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santraine</LastName><ForeName>Valerie</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Niset</LastName><ForeName>Francine</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dumont</LastName><ForeName>Julien</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laugeais</LastName><ForeName>Victor</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bon</LastName><ForeName>Mathilde</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ouk</LastName><ForeName>Thavarak</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Potey</LastName><ForeName>Camille</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leclercq</LastName><ForeName>Celine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gers</LastName><ForeName>Elise</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salachas</LastName><ForeName>Francois</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bruneteau</LastName><ForeName>Gaelle</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lacomblez</LastName><ForeName>Lucette</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Socha</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pineau</LastName><ForeName>Fanny</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lenglet</LastName><ForeName>Timothee</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Folhinha</LastName><ForeName>Patricia Doucelance St&#xe9;phanie</ForeName><Initials>PDS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bordet</LastName><ForeName>Amandine</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Royer</LastName><ForeName>Hugo</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Osman</LastName><ForeName>Nadia</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khelifa</LastName><ForeName>Sabah Ait</ForeName><Initials>SA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corcia</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beltran</LastName><ForeName>Stephane</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carmier</LastName><ForeName>Delphine</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barantin</LastName><ForeName>Laurent</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blasco</LastName><ForeName>H&#xe9;l&#xe8;ne</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bakkouche</LastName><ForeName>Salah Eddine</ForeName><Initials>SE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mouzouri</LastName><ForeName>Mohad</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Antoine</LastName><ForeName>Jean-Christophe</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Camdessanch&#xe9;</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dimier</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kaminsky</LastName><ForeName>Anne-Laure</ForeName><Initials>AL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Court-Fortune</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boutet</LastName><ForeName>Claire</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalo</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Visneux</LastName><ForeName>Vincent</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferraud</LastName><ForeName>Karine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berlier</LastName><ForeName>Georgette</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Genestet</LastName><ForeName>Steeve</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gut-Gobert</LastName><ForeName>Christophe</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salem</LastName><ForeName>Douraied Ben</ForeName><Initials>DB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nicolas</LastName><ForeName>Pauline</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Larvor</LastName><ForeName>Sabine</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mouly</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roux</LastName><ForeName>Liana Le</ForeName><Initials>LL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Postec</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bezeazux</LastName><ForeName>Camille</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosec</LastName><ForeName>Sylvain</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fortin-Prunier</LastName><ForeName>H&#xe9;l&#xe8;ne</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Novert</LastName><ForeName>Gaelle</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menanteau</LastName><ForeName>Elsa</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Postec</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Denizot</LastName><ForeName>Magali</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bernard</LastName><ForeName>Emilien</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vial</LastName><ForeName>Christophe</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Broussole</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Svahn</LastName><ForeName>Juliette</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cam</LastName><ForeName>Pierre Le</ForeName><Initials>PL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berthezene</LastName><ForeName>Yves</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Combet</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jacqueline</LastName><ForeName>Sophie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neuillet</LastName><ForeName>Camille</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mansuy</LastName><ForeName>Adeline</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Camu</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Juntas-Morates</LastName></Investigator><Investigator ValidYN="Y"><LastName>Pageot</LastName></Investigator><Investigator ValidYN="Y"><LastName>Esselin</LastName></Investigator><Investigator ValidYN="Y"><LastName>Champfleur</LastName></Investigator><Investigator ValidYN="Y"><LastName>Roy-Bellina</LastName></Investigator><Investigator ValidYN="Y"><LastName>Lehmann</LastName><ForeName>Sylvain</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alphandry</LastName><ForeName>Sebastien</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Labar</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baudesson</LastName><ForeName>Leandra</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Attarian</LastName><ForeName>Sharam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grapperon</LastName><ForeName>Aude-Marie</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pouget</LastName><ForeName>Jean</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verschueren</LastName><ForeName>Annie</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bas</LastName><ForeName>Jaochim</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Finet-Monnier</LastName><ForeName>Armelle</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belingher</LastName><ForeName>Carole</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diallo</LastName><ForeName>Saran</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heddadji</LastName><ForeName>Nacime</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alphandery</LastName><ForeName>Sebastien</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baudesson</LastName><ForeName>Leandra</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reginensi</LastName><ForeName>Pascale</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Desnuelle</LastName><ForeName>Claude</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soriani</LastName><ForeName>Marie-H&#xe9;lene</ForeName><Initials>MH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chanalet</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mondot</LastName><ForeName>Lydiane</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Puma</LastName></Investigator><Investigator ValidYN="Y"><LastName>Pruvost</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barr&#xe9;</LastName><ForeName>Carole</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cintas</LastName><ForeName>Pascal</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bes</LastName><ForeName>Marie-Christine Arne</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Acket</LastName><ForeName>Blandine</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pariente</LastName><ForeName>J&#xe9;r&#xe9;mie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guilbaud</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonneville</LastName><ForeName>Fabrice</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Causse</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lagarde</LastName><ForeName>Thierry</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Geffroy</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Centelles</LastName><ForeName>Magali</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hermet-Douard</LastName><ForeName>V&#xe9;ronique</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pittion-Vouyovitch</LastName><ForeName>Sophie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Michon</LastName><ForeName>Maud</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meyer</LastName><ForeName>Myl&#xe8;ne</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lomazzi</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hossu</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chatelain</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Couratier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lautrette</LastName><ForeName>Geraldine</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vincent</LastName><ForeName>Francois</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Antonini</LastName><ForeName>Larie-Therese</ForeName><Initials>LT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Favard</LastName><ForeName>Florent</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boncoeur-Martel</LastName><ForeName>M L Arie-Paule</ForeName><Initials>MLA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chouly</LastName><ForeName>Marianne</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Desport</LastName><ForeName>Jean-Claude</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jesus</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fayemendy</LastName><ForeName>Phillipe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Labetoulle</LastName><ForeName>Cl&#xe9;mence</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Catteau</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Villeneuve</LastName><ForeName>Olivier</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Machat</LastName><ForeName>Selam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guy</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clavelou</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Greil</LastName><ForeName>Anick</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duclos</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jean</LastName><ForeName>Betty</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chassain</LastName><ForeName>Carine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tsoutsos</LastName><ForeName>Camille</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Speziale</LastName><ForeName>Claudine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cladiere</LastName><ForeName>Aur&#xe9;lie</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bouteloup</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farigon</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Argondo</LastName><ForeName>Sophia Sickout</ForeName><Initials>SS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dumont</LastName><ForeName>Emilie</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rouvet</LastName><ForeName>Sandrine</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Viader</LastName><ForeName>Fausto</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lefilliatre</LastName><ForeName>Mathilde</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mouton</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mondou</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Allouche</LastName><ForeName>Stephane</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bari-Makouri</LastName><ForeName>Rachida</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kolev</LastName><ForeName>Ivan</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pihan</LastName><ForeName>Morgane</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ho</LastName><ForeName>Helene Le</ForeName><Initials>HL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Catroux</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castel</LastName><ForeName>Maela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rigal</LastName><ForeName>Marine</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellot</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vomscheid</LastName><ForeName>Maelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herv&#xe9;</LastName><ForeName>Marie-C&#xe9;cile</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duban</LastName><ForeName>Marie-Pierre</ForeName><Initials>MP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vieillart</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cassereau</LastName><ForeName>Julien</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Codron</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pautot</LastName><ForeName>Vivien</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meslier</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trzepizur</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tanguy</LastName><ForeName>J Y</ForeName><Initials>JY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Allain</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thiery</LastName><ForeName>Cecile</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reynier</LastName><ForeName>Pascal</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barbe</LastName><ForeName>Tiphaine</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vialle-Soubranne</LastName></Investigator><Investigator ValidYN="Y"><LastName>Vienne</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Olivier</LastName><ForeName>Audrey</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Jeanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bost</LastName><ForeName>Marie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fournier</LastName></Investigator><Investigator ValidYN="Y"><LastName>Gay</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonicel</LastName><ForeName>Robin</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>El Mountassir</LastName><ForeName>Fouzia</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fischer</LastName><ForeName>Clara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mangin</LastName><ForeName>Jean-Fran&#xe7;ois</ForeName><Initials>JF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chupin</LastName><ForeName>Marie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cointepas</LastName><ForeName>Yann</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Accart</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gel&#xe9;</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fievet</LastName><ForeName>Florine</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chabel</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Derenaucourt</LastName><ForeName>Virginie</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Facon</LastName><ForeName>Lo&#xef;c</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Njosse</LastName><ForeName>Yanick Tchantchou</ForeName><Initials>YT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hisbergues</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deplanque</LastName></Investigator><Investigator ValidYN="Y"><LastName>Tabuenca</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cazal&#xe8;re</LastName><ForeName>Marie-France</ForeName><Initials>MF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Couratier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Camu</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corcia</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Desnuelle</LastName><ForeName>Claude</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caillier</LastName><ForeName>Maxime</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Danel</LastName><ForeName>V&#xe9;ronique</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morerau</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laugeais</LastName><ForeName>Victor</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lecocq</LastName><ForeName>Amelie</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Potin</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frisch</LastName><ForeName>Marie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>L&#xe9;on</LastName><ForeName>Marie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devos</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salachas</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pradat</LastName><ForeName>Pierre-Francois</ForeName><Initials>PF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lacomblez</LastName><ForeName>Lucette</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Camdessanch&#xe9;</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Attarian</LastName><ForeName>Sharam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Langlet</LastName><ForeName>Timoth&#xe9;e</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blasco</LastName><ForeName>H&#xe9;l&#xe8;ne</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dupuis</LastName><ForeName>Luc</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bon</LastName><ForeName>Mathilde</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bernard</LastName><ForeName>Emilien</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cassereau</LastName><ForeName>Julien</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soriani</LastName><ForeName>Marie-H&#xe9;l&#xe8;ne</ForeName><Initials>MH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raoul</LastName><ForeName>Cedric</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lehman</LastName><ForeName>Sylvain</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turgeman</LastName><ForeName>Sabine</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goutines</LastName><ForeName>Val&#xe9;rie</ForeName><Initials>V</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37103756</ArticleId><ArticleId IdType="doi">10.1007/s00415-023-11727-w</ArticleId><ArticleId IdType="pii">10.1007/s00415-023-11727-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Robberecht W, Philips T (2013) The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 14:248&#x2013;264. https://doi.org/10.1038/nrn3430</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344:1688&#x2013;1700. https://doi.org/10.1056/nejm200105313442207</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Bowser R, Bruijn L, Dupuis L, Ludolph A, McGrath M, Manfredi G, Maragakis N, Miller RG, Pullman SL, Rutkove SB, Shaw PJ, Shefner J, Fischbeck KH (2013) Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 14:19&#x2013;32. https://doi.org/10.3109/21678421.2013.778554</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.778554</ArticleId><ArticleId IdType="pubmed">23678877</ArticleId><ArticleId IdType="pmc">4284067</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Benatar M (2015) Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis. Muscle Nerve 51:14&#x2013;18. https://doi.org/10.1002/mus.24470</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24470</ArticleId><ArticleId IdType="pubmed">25288265</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J, Paul P, Jorg C (2007) Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 68:1571&#x2013;1575. https://doi.org/10.1212/01.wnl.0000260965.20021.47</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000260965.20021.47</ArticleId><ArticleId IdType="pubmed">17485643</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, Rowland LP (2006) The natural history of primary lateral sclerosis. Neurology 66:647&#x2013;653. https://doi.org/10.1212/01.wnl.0000200962.94777.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000200962.94777.71</ArticleId><ArticleId IdType="pubmed">16534101</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraemer M, Buerger M, Berlit P (2010) Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis. Clin Neurol Neurosurg 112:103&#x2013;105. https://doi.org/10.1016/j.clineuro.2009.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2009.10.014</ArticleId><ArticleId IdType="pubmed">19931253</ArticleId></ArticleIdList></Reference><Reference><Citation>Witzel S, Frauhammer F, Steinacker P, Devos D, Pradat PF, Meininger V, Halbgebauer S, Oeckl P, Schuster J, Anders S, Dorst J, Otto M, Ludolph AC (2021) Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials. Transl Neurodegener 10:31. https://doi.org/10.1186/s40035-021-00257-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00257-y</ArticleId><ArticleId IdType="pubmed">34433481</ArticleId><ArticleId IdType="pmc">8390195</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Z, Liu Q, Liu M, Yang X, Shen D, Sun X, He D, Zhang K, Shang L, Zhang X, Cui L (2022) Survival analysis of clinical and genetic factors in an amyotrophic lateral sclerosis cohort from China. Neurol Res 44:651&#x2013;658. https://doi.org/10.1080/01616412.2022.2029292</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01616412.2022.2029292</ArticleId><ArticleId IdType="pubmed">35193472</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, Martin S, McDermott CJ, Thompson AG, Pinto S, Kobeleva X, Rosenbohm A, Stubendorff B, Sommer H, Middelkoop BM, Dekker AM, van Vugt J, van Rheenen W, Vajda A, Heverin M, Kazoka M, Hollinger H, Gromicho M, K&#xf6;rner S, Ringer TM, R&#xf6;diger A, Gunkel A, Shaw CE, Bredenoord AL, van Es MA, Corcia P, Couratier P, Weber M, Grosskreutz J, Ludolph AC, Petri S, de Carvalho M, Van Damme P, Talbot K, Turner MR, Shaw PJ, Al-Chalabi A, Chi&#xf2; A, Hardiman O, Moons KGM, Veldink JH, van den Berg LH (2018) Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 17:423&#x2013;433. https://doi.org/10.1016/s1474-4422(18)30089-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(18)30089-9</ArticleId><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F, Siciliano M, Femiano C, Santangelo G, Lunetta C, Calvo A, Moglia C, Marinou K, Ticozzi N, Ferro C, Scial&#xf2; C, Sorar&#xf9; G, Conte A, Falzone YM, Tortelli R, Russo M, Sansone VA, Chi&#xf2; A, Mora G, Silani V, Volanti P, Caponnetto C, Querin G, Sabatelli M, Riva N, Logroscino G, Messina S, Fasano A, Monsurr&#xf2; MR, Tedeschi G, Mandrioli J (2019) Comparative analysis of C9orf72 and sporadic disease in a large multicenter ALS population: the effect of male sex on survival of C9orf72 positive patients. Front Neurosci. https://doi.org/10.3389/fnins.2019.00485</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00485</ArticleId><ArticleId IdType="pubmed">31849599</ArticleId><ArticleId IdType="pmc">6901677</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Devenney EM, Strikwerda-Brown C, Hodges JR, Piguet O, Kiernan MC (2020) Phenotypic variability in ALS-FTD and effect on survival. Neurology 94:e2005&#x2013;e2013. https://doi.org/10.1212/wnl.0000000000009398</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000009398</ArticleId><ArticleId IdType="pubmed">32277059</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou YN, Chen YH, Dong SQ, Yang WB, Qian T, Liu XN, Cheng Q, Wang JC, Chen XJ (2021) Role of blood neurofilaments in the prognosis of amyotrophic lateral sclerosis: a meta-analysis. Front Neurol. https://doi.org/10.3389/fneur.2021.712245</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.712245</ArticleId><ArticleId IdType="pubmed">35197917</ArticleId><ArticleId IdType="pmc">8733999</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mendili MM, Cohen-Adad J, Pelegrini-Issac M, Rossignol S, Morizot-Koutlidis R, Marchand-Pauvert V, Iglesias C, Sangari S, Katz R, Lehericy S, Benali H, Pradat PF (2014) Multi-parametric spinal cord MRI as potential progression marker in amyotrophic lateral sclerosis. PLoS ONE 9:e95516. https://doi.org/10.1371/journal.pone.0095516</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095516</ArticleId><ArticleId IdType="pubmed">24755826</ArticleId><ArticleId IdType="pmc">3995720</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency. Guideline on clinical investigation of medicinal products for the treatment of amyotrophic lateral sclerosis 2016 [Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-investigation-medicinal-products-treatment-amyotrophic-lateral-sclerosis_en.pdf . Accessed 06 Oct 2022.</Citation></Reference><Reference><Citation>U.S. Food and Drug Administration. Guidance for industry: amyotrophic lateral sclerosis: developing drugs for treatment 2019 [Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/amyotrophic-lateral-sclerosis-developing-drugs-treatment-guidance-industry .</Citation></Reference><Reference><Citation>Steering committee members of The ALS CNTF Treatment Study Phase I-II Study Group (1996) The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol 53:141&#x2013;147. https://doi.org/10.1001/archneur.1996.00550020045014</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1996.00550020045014</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk R, Kliest T, van den Berg L (2020) Current trends in the clinical trial landscape for amyotrophic lateral sclerosis. Curr Opin Neurol 33:655&#x2013;661. https://doi.org/10.1097/WCO.0000000000000861</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000861</ArticleId><ArticleId IdType="pubmed">32796282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet 377:942&#x2013;955. https://doi.org/10.1016/s0140-6736(10)61156-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mendili MM, Querin G, Bede P, Pradat P-F (2019) Spinal cord imaging in amyotrophic lateral sclerosis: historical concepts&#x2014;novel techniques. Front Neurol 10:350. https://doi.org/10.3389/fneur.2019.00350</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00350</ArticleId><ArticleId IdType="pubmed">31031688</ArticleId><ArticleId IdType="pmc">6474186</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Adad J, El Mendili MM, Morizot-Koutlidis R, Leh&#xe9;ricy S, Meininger V, Blancho S, Rossignol S, Benali H, Pradat PF (2013) Involvement of spinal sensory pathway in ALS and specificity of cord atrophy to lower motor neuron degeneration. Amyotroph Lateral Scler Frontotemporal Degener 14:30&#x2013;38. https://doi.org/10.3109/17482968.2012.701308</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.701308</ArticleId><ArticleId IdType="pubmed">22881412</ArticleId></ArticleIdList></Reference><Reference><Citation>Branco LM, De Albuquerque M, De Andrade HM, Bergo FP, Nucci A, Fran&#xe7;a MC Jr (2014) Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 15:93&#x2013;97. https://doi.org/10.3109/21678421.2013.852589</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.852589</ArticleId><ArticleId IdType="pubmed">24219347</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair G, Carew JD, Usher S, Lu D, Hu XP, Benatar M (2010) Diffusion tensor imaging reveals regional differences in the cervical spinal cord in amyotrophic lateral sclerosis. Neuroimage 53:576&#x2013;583. https://doi.org/10.1016/j.neuroimage.2010.06.060</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2010.06.060</ArticleId><ArticleId IdType="pubmed">20600964</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, El Mendili MM, Lenglet T, Delphine S, Marchand-Pauvert V, Benali H, Pradat PF (2017) Spinal cord multi-parametric magnetic resonance imaging for survival prediction in amyotrophic lateral sclerosis. Eur J Neurol 24:1040&#x2013;1046. https://doi.org/10.1111/ene.13329</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13329</ArticleId><ArticleId IdType="pubmed">28586096</ArticleId></ArticleIdList></Reference><Reference><Citation>Grolez G, Kyheng M, Lopes R, Moreau C, Timmerman K, Auger F, Kuchcinski G, Duhamel A, Jissendi-Tchofo P, Besson P, Laloux C, Petrault M, Devedjian JC, P&#xe9;rez T, Pradat PF, Defebvre L, Bordet R, Danel-Brunaud V, Devos D (2018) MRI of the cervical spinal cord predicts respiratory dysfunction in ALS. Sci Rep 8:1828. https://doi.org/10.1038/s41598-018-19938-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-19938-2</ArticleId><ArticleId IdType="pubmed">29379040</ArticleId><ArticleId IdType="pmc">5789036</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, El Mendili MM, Bede P, Delphine S, Lenglet T, Marchand-Pauvert V, Pradat PF (2018) Multimodal spinal cord MRI offers accurate diagnostic classification in ALS. J Neurol Neurosurg Psychiatry 89:1220&#x2013;1221. https://doi.org/10.1136/jnnp-2017-317214</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317214</ArticleId><ArticleId IdType="pubmed">29353238</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293&#x2013;299. https://doi.org/10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13&#x2013;21. https://doi.org/10.1016/s0022-510x(99)00210-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros C, De Leener B, Dupont SM, Martin AR, Fehlings MG, Bakshi R, Tummala S, Auclair V, McLaren DG, Callot V, Cohen-Adad J, Sdika M (2018) Automatic spinal cord localization, robust to MRI contrasts using global curve optimization. Med Image Anal 44:215&#x2013;227. https://doi.org/10.1016/j.media.2017.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.media.2017.12.001</ArticleId><ArticleId IdType="pubmed">29288983</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonov VS, Le Troter A, Taso M, De Leener B, L&#xe9;v&#xea;que G, Benhamou M, Sdika M, Benali H, Pradat PF, Collins DL, Callot V, Cohen-Adad J (2014) Framework for integrated MRI average of the spinal cord white and gray matter: the MNI-Poly-AMU template. Neuroimage 102:2817&#x2013;2827. https://doi.org/10.1016/j.neuroimage.2014.08.057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2014.08.057</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;vy S, Benhamou M, Naaman C, Rainville P, Callot V, Cohen-Adad J (2015) White matter atlas of the human spinal cord with estimation of partial volume effect. Neuroimage 119:262&#x2013;271. https://doi.org/10.1016/j.neuroimage.2015.06.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2015.06.040</ArticleId><ArticleId IdType="pubmed">26099457</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao Y, Lin F, Wu J, Li H, Wang L, Jin Z, Wang S, Cao Y (2018) A supplementary grading scale combining lesion-to-eloquence distance for predicting surgical outcomes of patients with brain arteriovenous malformations. J Neurosurg 128:530&#x2013;540. https://doi.org/10.3171/2016.10.Jns161415</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2016.10.Jns161415</ArticleId><ArticleId IdType="pubmed">28362235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M, Madia F, Conte A, Luigetti M, Zollino M, Mancuso I, Lo Monaco M, Lippi G, Tonali P (2008) Natural history of young-adult amyotrophic lateral sclerosis. Neurology 71:876&#x2013;881. https://doi.org/10.1212/01.wnl.0000312378.94737.45</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000312378.94737.45</ArticleId><ArticleId IdType="pubmed">18596241</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Zhang B, Chen R, Tang L, Liu R, Yang Y, Yang Y, Liu X, Ye S, Zhan S, Fan D (2015) Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China. J Neurol Neurosurg Psychiatry 86:1075&#x2013;1081. https://doi.org/10.1136/jnnp-2015-310471</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310471</ArticleId><ArticleId IdType="pubmed">26124198</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquin M, El Mendili MM, Gros C, Dupont SM, Cohen-Adad J, Pradat PF (2018) Spinal cord gray matter atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 39:184&#x2013;192. https://doi.org/10.3174/ajnr.A5427</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5427</ArticleId><ArticleId IdType="pubmed">29122760</ArticleId><ArticleId IdType="pmc">7410702</ArticleId></ArticleIdList></Reference><Reference><Citation>Barry RL, Torrado-Carvajal A, Kirsch JE, Arabasz GE, Albrecht DS, Alshelh Z, Pijanowski O, Lewis AJ, Keegan M, Reynolds B, Knight PC, Morrissey EJ, Loggia ML, Atassi N, Hooker JM, Babu S (2022) Selective atrophy of the cervical enlargement in whole spinal cord MRI of amyotrophic lateral sclerosis. NeuroImage Clin 36:103199. https://doi.org/10.1016/j.nicl.2022.103199</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2022.103199</ArticleId><ArticleId IdType="pubmed">36137496</ArticleId><ArticleId IdType="pmc">9668597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Hardiman O (2014) Lessons of ALS imaging: Pitfalls and future directions&#x2014;a critical review. NeuroImage Clin 4:436&#x2013;443. https://doi.org/10.1016/j.nicl.2014.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2014.02.011</ArticleId><ArticleId IdType="pubmed">24624329</ArticleId><ArticleId IdType="pmc">3950559</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao B, Wei Q, Ou R, Zhang L, Hou Y, Chen Y, Shang H (2019) Neurophysiological index is associated with the survival of patients with amyotrophic lateral sclerosis. Clin Neurophysiol 130:1730&#x2013;1733. https://doi.org/10.1016/j.clinph.2019.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2019.05.012</ArticleId><ArticleId IdType="pubmed">31164255</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>